Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucoidan For Patients With Chemotherapy-Related Fatigue
NCT06855524Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Mar 2025
- Primary completion
- Jan 2029
- Modality
- Polysaccharide, Nutraceutical
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-related fatigue (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in fatigue at 8 weeks. Started Mar 2025; status: recruiting.
02
Conditions
chemotherapy-related fatigue
Beyond the preview
Go deeper on NCT06855524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06855524.